Hu-Mikβ1 was evaluated in a Phase I clinical trial in patients with T-cell large granular lymphocyte leukemia. Hu-Mikβ1 was shown to be safe in Phase I trials; however, no therapeutic efficacy ...

“lymphocytes from liver transplant recipients are older 'biologically' than lymphocytes from ... controls.” A large prospective study with samples collected before and at intervals after ...